Literature DB >> 8467245

Serum pepsinogens in relation to precancerous gastric lesions in a population at high risk for gastric cancer.

W C You1, W J Blot, L Zhang, R W Kneller, J Y Li, M L Jin, Y S Chang, X R Zeng, L Zhao, J F Fraumeni.   

Abstract

Concentrations of serum pepsinogens (PG) I and II were determined for 3252 randomly selected adults who participated in a population-based gastroscopic screening in an area of China with one of the world's highest rates of gastric cancer. PG I and II concentrations in both sexes tended to be higher than reported in other countries, with levels generally higher among males than females. PG I tended to decrease and PG II to increase with age, but the most pronounced associations were between PG I:II ratios and gastric histology. Median PG I:II ratios monotonically declined from 9.1 to 7.2 to 5.7 to 5.4 to 3.8 among those with superficial gastritis, chronic atrophic gastritis, intestinal metaplasia, dysplasia, and stomach cancer, respectively. The prevalence of dysplasia was nearly 3 times greater among those with PG I:II ratios less than 3 compared with those whose PG I:II ratios were greater than 10. While average levels differed significantly among the histologic groups, the PG I:II ratios were neither sensitive nor specific markers of an individual's likelihood of advanced gastric lesions in this population.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8467245

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  13 in total

1.  Gastric cancer screening using the serum pepsinogen test method.

Authors:  Kazumasa Miki
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

Review 2.  Implementation of gastric cancer screening - the global experience.

Authors:  Mārcis Leja; Weicheng You; M Constanza Camargo; Hiroshi Saito
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-09-28       Impact factor: 3.043

3.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

4.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Endoscopy       Date:  2011-12-23       Impact factor: 10.093

5.  Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort.

Authors:  J-S Ren; F Kamangar; Y-L Qiao; P R Taylor; H Liang; S M Dawsey; B Liu; J-H Fan; C C Abnet
Journal:  Gut       Date:  2009-01-09       Impact factor: 23.059

6.  Serum pepsinogens and risk of esophageal squamous dysplasia.

Authors:  Farin Kamangar; Lena Diaw; Wen-Qiang Wei; Christian C Abnet; Guo-Qing Wang; Mark J Roth; Bing Liu; Ning Lu; Carol Giffen; You-Lin Qiao; Sanford M Dawsey
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

7.  Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study.

Authors:  Huakang Tu; Liping Sun; Xiao Dong; Yuehua Gong; Qian Xu; Jingjing Jing; Qi Long; W Dana Flanders; Roberd M Bostick; Yuan Yuan
Journal:  Int J Cancer       Date:  2014-06-19       Impact factor: 7.396

8.  Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach.

Authors:  Guoqin Yu; Mitchell H Gail; Jianxin Shi; Vanja Klepac-Ceraj; Bruce J Paster; Bruce A Dye; Guo-Qing Wang; Wen-Qiang Wei; Jin-Hu Fan; You-Lin Qiao; Sanford M Dawsey; Neal D Freedman; Christian C Abnet
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-03       Impact factor: 4.254

9.  Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer.

Authors:  Ming-yang Song; Kai-feng Pan; Hui-juan Su; Lian Zhang; Jun-ling Ma; Ji-you Li; Yasuhito Yuasa; Daehee Kang; Yong Sung Kim; Wei-cheng You
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

10.  Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort.

Authors:  C C Abnet; W Zheng; W Ye; F Kamangar; B-T Ji; C Persson; G Yang; H-L Li; N Rothman; X-O Shu; Y-T Gao; W-H Chow
Journal:  Br J Cancer       Date:  2011-03-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.